Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
This study aimed to investigate the association between serum 25-hydroxyvitamin D3 (25(OH)D3) levels and cognitive impairment (CI) in middle-aged and elderly individuals with type 2 diabetes mellitus (T2DM).
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cross-sectional study.
Cross-sectional study
Examines a population at a particular point in time.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
This cross-sectional study included 221 middle-aged and elderly patients with T2DM, aged 50 to 80 years.
Source: Abstract.
Participants were divided into a group without cognitive impairment (n = 131, 59.28%) and a group with cognitive impairment (n = 90, 40.72%) based on cognitive function status.
Source: Abstract.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Serum 25(OH)D3 level is associated with cognitive impairment in middle-aged and elderly patients with type 2 diabetes mellitus
Cross-sectional study · Frontiers in Endocrinology · 2026
Original publication title
Serum 25(OH)D3 level is associated with cognitive impairment in middle-aged and elderly patients with type 2 diabetes mellitus
Copyright © 2026 Wu, Wei, Zhang and Han.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
This study aimed to investigate the association between serum 25-hydroxyvitamin D3 (25(OH)D3) levels and cognitive impairment (CI) in middle-aged and elderly individuals with type 2 diabetes mellitus (T2DM). Additionally, we sought to evaluate the potential of serum 25(OH)D3 as a marker associated with CI and to identify relevant influencing factors.
Source: ObjectivesAbstract: What methods does the paper describe?
This cross-sectional study included 221 middle-aged and elderly patients with T2DM, aged 50 to 80 years. Participants were divided into a group without cognitive impairment (n = 131, 59.28%) and a group with cognitive impairment (n = 90, 40.72%) based on cognitive function status. Demographic characteristics, clinical indicators (e.g., age, disease duration, body composition, comorbidities), and laboratory test results (e.g., 25(OH)D3, fasting C-peptide, fasting insulin, blood lipids) were collected. Logistic regression analysis was used to examine the association between 25(OH)D3 and cognitive impairment.
Analyses included univariate logistic regression, multivariate regression adjusted for three sets of confounders, subgroup analyses, interaction tests, and ROC curve analyses.
Source: MethodsAbstract: Results
The two groups showed statistically significant differences in age, disease duration, fasting C-peptide, fasting insulin, cholesterol, serum 25(OH)D3 levels, and 25(OH)D3 quartile distribution (P < 0.05). Differences in other indicators were not statistically significant (P > 0.05). Logistic regression analysis revealed that higher serum 25(OH)D3 levels were significantly associated with a lower prevalence of cognitive impairment. This association remained robust after adjusting for multiple confounders (including gender, hypertension, cerebral infarction, and coronary heart disease) in Model 3 (OR = 0.92, 95% CI: 0.88 to 0.97, P < 0.001).
In the 25(OH)D3 quartile subgroup analysis, compared with the Q1 group, the Q3 (OR = 0.35, P = 0.034) and Q4 (OR = 0.25, P = 0.004) groups showed significantly lower odds of cognitive impairment, with a significant trend (P = 0.003). Receiver operating characteristic (ROC) curve analysis revealed an area under the curve (AUC) of 0.65 (95% CI: 0.58 to 0.72) for 25(OH)D3 in identifying cognitive impairment. Interaction tests indicated that factors such as gender, hypertension, cerebral infarction, and fatty liver did not significantly modify the association between 25(OH)D3 and cognitive impairment (P for interaction > 0.05).
Source: ResultsAbstract: Conclusions
This study found that 25(OH)D3 levels were negatively correlated with the prevalence of cognitive impairment in middle-aged and elderly individuals with T2DM. Higher 25(OH)D3 levels are associated with lower odds of cognitive impairment, and 25(OH)D3 may have potential as a marker for cognitive impairment in this population. These findings highlight 25(OH)D3 as a potential factor of interest for further research into the prevention and intervention of cognitive impairment in middle-aged and elderly patients with T2DM.
Source: ConclusionsAuthors’ abstract
Objectives
This study aimed to investigate the association between serum 25-hydroxyvitamin D3 (25(OH)D3) levels and cognitive impairment (CI) in middle-aged and elderly individuals with type 2 diabetes mellitus (T2DM). Additionally, we sought to evaluate the potential of serum 25(OH)D3 as a marker associated with CI and to identify relevant influencing factors.
Methods
This cross-sectional study included 221 middle-aged and elderly patients with T2DM, aged 50 to 80 years. Participants were divided into a group without cognitive impairment (n = 131, 59.28%) and a group with cognitive impairment (n = 90, 40.72%) based on cognitive function status. Demographic characteristics, clinical indicators (e.g., age, disease duration, body composition, comorbidities), and laboratory test results (e.g., 25(OH)D3, fasting C-peptide, fasting insulin, blood lipids) were collected. Logistic regression analysis was used to examine the association between 25(OH)D3 and cognitive impairment.
Analyses included univariate logistic regression, multivariate regression adjusted for three sets of confounders, subgroup analyses, interaction tests, and ROC curve analyses.
Results
The two groups showed statistically significant differences in age, disease duration, fasting C-peptide, fasting insulin, cholesterol, serum 25(OH)D3 levels, and 25(OH)D3 quartile distribution (P < 0.05). Differences in other indicators were not statistically significant (P > 0.05). Logistic regression analysis revealed that higher serum 25(OH)D3 levels were significantly associated with a lower prevalence of cognitive impairment. This association remained robust after adjusting for multiple confounders (including gender, hypertension, cerebral infarction, and coronary heart disease) in Model 3 (OR = 0.92, 95% CI: 0.88 to 0.97, P < 0.001).
In the 25(OH)D3 quartile subgroup analysis, compared with the Q1 group, the Q3 (OR = 0.35, P = 0.034) and Q4 (OR = 0.25, P = 0.004) groups showed significantly lower odds of cognitive impairment, with a significant trend (P = 0.003). Receiver operating characteristic (ROC) curve analysis revealed an area under the curve (AUC) of 0.65 (95% CI: 0.58 to 0.72) for 25(OH)D3 in identifying cognitive impairment. Interaction tests indicated that factors such as gender, hypertension, cerebral infarction, and fatty liver did not significantly modify the association between 25(OH)D3 and cognitive impairment (P for interaction > 0.05).
Conclusions
This study found that 25(OH)D3 levels were negatively correlated with the prevalence of cognitive impairment in middle-aged and elderly individuals with T2DM. Higher 25(OH)D3 levels are associated with lower odds of cognitive impairment, and 25(OH)D3 may have potential as a marker for cognitive impairment in this population. These findings highlight 25(OH)D3 as a potential factor of interest for further research into the prevention and intervention of cognitive impairment in middle-aged and elderly patients with T2DM.
Publication and source details
Original title: Serum 25(OH)D3 level is associated with cognitive impairment in middle-aged and elderly patients with type 2 diabetes mellitus
Xin Wu; Xiaoyang Wei; Lei Zhang; XiaoFang Han
Frontiers in Endocrinology · 2026
* Correspondence: XiaoFang Han, hxfanghf@sina.comCopyright © 2026 Wu, Wei, Zhang and Han.2026Wu, Wei, Zhang and Hanhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. This research and the publication of this article received no financial support from any institutions or individuals.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T23:24:36.909767+00:00
DOI: 10.3389/fendo.2026.1803549 · PMC13132787